Work

Comparison between 150 mg monthly and 5 mg daily risedronate in postmenopausal osteoporosis; Effects on bone quality and bone remodelling

Year: 2009

Type: article

Study design: Clinical Trial

Source: Bone

DOI: 10.1016/j.bone.2009.03.397

Authors: P. Chavassieux, N. Portero, S. Xu, R. Eusebio, P. Delmas, J. Zanchetta, I. Valter, R. Recker

Institutions: Inserm, Procter & Gamble (United States), Universidad del Salvador, Instituto de Diagnóstico e Investigaciones Metabólicas, Institute for Medical Research, Creighton University

Language: English

Topic: Bone health and osteoporosis research

Subfield: Orthopedics and Sports Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1967109199

FWCI:

Cites:

Cited by: 1

Related to: 10